Axcelead DDP has become a certified provider of Single Cell Gene Expression Solution, from 10x Genomics
We’re delighted to announce that Axcelead Drug Discovery Partners, Inc. (“Axcelead DDP”) has received official certification from...
Achieved the First Milestone in Drug Discovery Support to Otsuka Pharmaceutical
May 27, 2024 – Axcelead Drug Discovery Partners, Inc. (HQ: Fujisawa-city, Kanagawa; “Axcelead DDP”) announces that the first...
Change of Representative Director
Kanagawa, Japan, April 1, 2024 --- Axcelead Drug Discovery Partners, Inc (hereafter Axcelead DDP) announced that the...
Axcelead DDP’s English Version of Official Website Renewed
We are pleased to announce the renewal of Axcelead DDP's English version of the official website. The...
Axcelead Drug Discovery Partners and Acadia Pharmaceuticals Launch 2nd Drug Discovery Project in Neuroscience
December 25, 2023 – Axcelead Drug Discovery Partners, Inc. (HQ: Fujisawa, Kanagawa, Japan; hereinafter referred to as “Axcelead...
In-Vivo Science and Axcelead DDP Entered into Cooperative Agreement for Drug Discovery Services Using Disease Model Animals
In-Vivo Science, Inc. (Headquarters: Meguro-ku, Tokyo; Branch Office: Kawasaki City, Kanagawa Prefecture; President: Koji Yoshimura; hereinafter “In-Vivo...